Lista de obras -

ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2

artículo científico publicado en 2016

Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial

artículo científico publicado en 2013

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

artículo científico publicado en 2008

Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data

scientific article published on 01 September 2019

Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience

artículo científico publicado en 2014

Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial.

artículo científico publicado en 2014

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

scientific article published on 18 March 2019

Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial

artículo científico publicado en 2014

Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis

artículo científico publicado en 2010

Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis

artículo científico publicado en 2009

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second [...]

artículo científico publicado en 2008

Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale

artículo científico publicado en 2016

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Nether

artículo científico publicado en 2015

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.

artículo científico publicado en 2016

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.

artículo científico publicado en 2014

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke

artículo científico publicado en 2013

Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials

artículo científico publicado en 2014

Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

artículo científico publicado en 2017

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial

artículo científico publicado en 2014

Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage

scientific article published on 12 November 2018

Telmisartan to prevent recurrent stroke and cardiovascular events

artículo científico publicado en 2008

The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.

artículo científico publicado en 2010

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

artículo científico publicado en 2014

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial

artículo científico publicado en 2015

Lista de obras de

ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2

Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data

Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience

Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial.

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial

Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis

Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second [...]

Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Nether

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke

Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials

Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial

Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage

Telmisartan to prevent recurrent stroke and cardiovascular events

The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial